A股異動丨9月3日閲兵!軍工股再掀升停潮,萬里馬4日3板,吉大正元4連板
A股市場軍工股再掀升停潮,其中,*ST廣道30CM升停,萬里馬(4日3板)、中光防雷、國瑞科技(2連板)20CM升停,中科海訊升超14%,北方長龍升近14%,科翔股份升超11%,華強科技升超10%,吉大正元(4連板)、北方導航(2連板)、建設工業(2連板)、中光學(2連板)、長城軍工(2連板)、格爾軟件、海洋王、中京電子10CM升停,消息面上,9月3日將舉行閲兵,參閲的所有裝備均為國產現役主戰裝備,在展示新一代傳統武器裝備的基礎上,也安排部分無人智能、水下作戰、網電攻防、高超聲速等新型作戰力量參閲。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.